focus -WSS

focus

author：hotspot 2025-08-24 04:06:31 - browse：4

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Medicare Advantage plans can’t deny care with AI, CMS warns

focus

WSS

Sea level rise could wash away turtle breeding grounds around the world, researchers say

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

The Biogen Aduhelm mess could happen again

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Biogen nominates mother of director’s child to replace him on board

focus

focus

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Novo pauses ads for weight loss drug Wegovy amid demand

Anesthesiologist group: stop taking Ozempic before surgery

Adopting new red light myopia treatments may be short

United colonoscopy coverage change 'may cost lives,' doctors say

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Novavax promises a turnaround & Lilly roils the obesity market

Timeline: Key moments in fight for gay rights

Alkermes shareholders re

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Bispecific antibodies are next new thing in cancer immunotherapy

Bernie brings in new pharma CEOs to talk drug prices

Patients, doctors are clashing about side effects of hormonal birth control

focus

focus

explore

focus